Prof. Dr.

Vigo Heissmeyer

B2
Associated Investigator

Prof. Dr.

Vigo Heissmeyer

Biomedical Center and Institute for Immunology, Faculty of Medicine

Ludwig-Maximilians-Universität München

Research background

T helper cells orchestrate adaptive immune responses by differentiating into specialized subsets that direct pathogen clearance, tumor surveillance, or inflammatory reactions. The acquisition of distinct T cell fates depends on tightly regulated gene expression programs that control development, activation, and effector function. While transcriptional networks have been extensively studied, how post-transcriptional mechanisms shape T helper cell differentiation and how their dysregulation contributes to autoimmunity, chronic infection, or cancer remain key open questions in immunology.

The research of Vigo Heissmeyer focuses on the molecular mechanisms of post-transcriptional gene regulation in T cells. His work investigates how RNA-binding proteins and mRNA modifications modulate the stability, translation, and processing of messenger RNAs that encode critical regulators of T cell fate decisions. By analyzing molecular interactions governing RNA metabolism during T cell activation and differentiation, he seeks to define how gene expression programs are controlled at the RNA level. Through mechanistic studies and the identification of diagnostic markers, this research advances understanding of immune regulation and supports the development of novel therapeutic strategies for inflammatory and immune-mediated diseases.

Research fields
Publications

The thymocyte-specific RNA-binding protein Arpp21 provides TCR repertoire diversity by binding to the 3'-UTR and promoting Rag1 mRNA expression.

Xu, M.; Ito-Kureha, T.; Kang, HS.; Chernev, A.; Raj, T.; Hoefig, KP.; Hohn, C.; Giesert, F.; Wang, Y.; Pan, W.; Ziętara, N.; Straub, T.; Feederle, R.; Daniel, C.; Adler, B.; König, J.; Feske, S.; Tsokos, GC.; Wurst, W.; Urlaub, H.; Sattler, M.; Kisielow, J.; Wulczyn, FG.; Łyszkiewicz, M.; Heissmeyer, V.

Nat Commun. · 2024

Show abstract

The regulation of thymocyte development by RNA-binding proteins (RBPs) is largely unexplored. We identify 642 RBPs in the thymus and focus on Arpp21, which shows selective and dynamic expression in early thymocytes. Arpp21 is downregulated in response to T cell receptor (TCR) and Ca signals. Downregulation requires Stim1/Stim2 and CaMK4 expression and involves Arpp21 protein phosphorylation, polyubiquitination and proteasomal degradation. Arpp21 directly binds RNA through its R3H domain, with a preference for uridine-rich motifs, promoting the expression of target mRNAs. Analysis of the Arpp21-bound transcriptome reveals strong interactions with the Rag1 3'-UTR. Arpp21-deficient thymocytes show reduced Rag1 expression, delayed TCR rearrangement and a less diverse TCR repertoire. This phenotype is recapitulated in Rag1 3'-UTR mutant mice harboring a deletion of the Arpp21 response region. These findings show how thymocyte-specific Arpp21 promotes Rag1 expression to enable TCR repertoire diversity until signals from the TCR terminate Arpp21 and Rag1 activities.

The function of Wtap in N-adenosine methylation of mRNAs controls T cell receptor signaling and survival of T cells.

Ito-Kureha, T.; Leoni, C.; Borland, K.; Cantini, G.; Bataclan, M.; Metzger, RN.; Ammann, G.; Krug, AB.; Marsico, A.; Kaiser, S.; Canzar, S.; Feske, S.; Monticelli, S.; König, J.; Heissmeyer, V.

Nat Immunol. · 2022

Show abstract

T cell antigen-receptor (TCR) signaling controls the development, activation and survival of T cells by involving several layers and numerous mechanisms of gene regulation. N-methyladenosine (mA) is the most prevalent messenger RNA modification affecting splicing, translation and stability of transcripts. In the present study, we describe the Wtap protein as essential for mA methyltransferase complex function and reveal its crucial role in TCR signaling in mouse T cells. Wtap and mA methyltransferase functions were required for the differentiation of thymocytes, control of activation-induced death of peripheral T cells and prevention of colitis by enabling gut RORγt regulatory T cell function. Transcriptome and epitranscriptomic analyses reveal that mA modification destabilizes Orai1 and Ripk1 mRNAs. Lack of post-transcriptional repression of the encoded proteins correlated with increased store-operated calcium entry activity and diminished survival of T cells with conditional genetic inactivation of Wtap. These findings uncover how mA modification impacts on TCR signal transduction and determines activation and survival of T cells.

Disrupting Roquin-1 interaction with Regnase-1 induces autoimmunity and enhances antitumor responses.

Behrens, G.; Edelmann, SL.; Raj, T.; Kronbeck, N.; Monecke, T.; Davydova, E.; Wong, EH.; Kifinger, L.; Giesert, F.; Kirmaier, ME.; Hohn, C.; de Jonge, LS.; Pisfil, MG.; Fu, M.; Theurich, S.; Feske, S.; Kawakami, N.; Wurst, W.; Niessing, D.; Heissmeyer, V.

Nat Immunol. · 2021

Show abstract

Roquin and Regnase-1 proteins bind and post-transcriptionally regulate proinflammatory target messenger RNAs to maintain immune homeostasis. Either the sanroque mutation in Roquin-1 or loss of Regnase-1 cause systemic lupus erythematosus-like phenotypes. Analyzing mice with T cells that lack expression of Roquin-1, its paralog Roquin-2 and Regnase-1 proteins, we detect overlapping or unique phenotypes by comparing individual and combined inactivation. These comprised spontaneous activation, metabolic reprogramming and persistence of T cells leading to autoimmunity. Here, we define an interaction surface in Roquin-1 for binding to Regnase-1 that included the sanroque residue. Mutations in Roquin-1 impairing this interaction and cooperative regulation of targets induced T follicular helper cells, germinal center B cells and autoantibody formation. These mutations also improved the functionality of tumor-specific T cells by promoting their accumulation in the tumor and reducing expression of exhaustion markers. Our data reveal the physical interaction of Roquin-1 with Regnase-1 as a hub to control self-reactivity and effector functions in immune cell therapies.

Roquin targets mRNAs in a 3'-UTR-specific manner by different modes of regulation.

Essig, K.; Kronbeck, N.; Guimaraes, JC.; Lohs, C.; Schlundt, A.; Hoffmann, A.; Behrens, G.; Brenner, S.; Kowalska, J.; Lopez-Rodriguez, C.; Jemielity, J.; Holtmann, H.; Reiche, K.; Hackermüller, J.; Sattler, M.; Zavolan, M.; Heissmeyer, V.

Nat Commun. · 2018

Show abstract

The RNA-binding proteins Roquin-1 and Roquin-2 redundantly control gene expression and cell-fate decisions. Here, we show that Roquin not only interacts with stem-loop structures, but also with a linear sequence element present in about half of its targets. Comprehensive analysis of a minimal response element of the Nfkbid 3'-UTR shows that six stem-loop structures cooperate to exert robust and profound post-transcriptional regulation. Only binding of multiple Roquin proteins to several stem-loops exerts full repression, which redundantly involved deadenylation and decapping, but also translational inhibition. Globally, most Roquin targets are regulated by mRNA decay, whereas a small subset, including the Nfat5 mRNA, with more binding sites in their 3'-UTRs, are also subject to translational inhibition. These findings provide insights into how the robustness and magnitude of Roquin-mediated regulation is encoded in complex cis-elements.

Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote T(H)17 differentiation.

Jeltsch, KM.; Hu, D.; Brenner, S.; Zöller, J.; Heinz, GA.; Nagel, D.; Vogel, KU.; Rehage, N.; Warth, SC.; Edelmann, SL.; Gloury, R.; Martin, N.; Lohs, C.; Lech, M.; Stehklein, JE.; Geerlof, A.; Kremmer, E.; Weber, A.; Anders, HJ.; Schmitz, I.; Schmidt-Supprian, M.; Fu, M.; Holtmann, H.; Krappmann, D.; Ruland, J.; Kallies, A.; Heikenwalder, M.; Heissmeyer, V.

Nat Immunol. · 2014

Show abstract

Humoral autoimmunity paralleled by the accumulation of follicular helper T cells (T(FH) cells) is linked to mutation of the gene encoding the RNA-binding protein roquin-1. Here we found that T cells lacking roquin caused pathology in the lung and accumulated as cells of the T(H)17 subset of helper T cells in the lungs. Roquin inhibited T(H)17 cell differentiation and acted together with the endoribonuclease regnase-1 to repress target mRNA encoding the T(H)17 cell-promoting factors IL-6, ICOS, c-Rel, IRF4, IκBNS and IκBζ. This cooperation required binding of RNA by roquin and the nuclease activity of regnase-1. Upon recognition of antigen by the T cell antigen receptor (TCR), roquin and regnase-1 proteins were cleaved by the paracaspase MALT1. Thus, this pathway acts as a 'rheostat' by translating TCR signal strength via graded inactivation of post-transcriptional repressors and differential derepression of targets to enhance T(H)17 differentiation.